Robinson Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-700
| Closed | -$735 | – | 234 |
|
|
2024
Q1 | $735 | Sell |
700
-216
| -24% | -$227 | ﹤0.01% | 172 |
|
|
2023
Q4 | $92 | Sell |
916
-104
| -10% | -$10 | ﹤0.01% | 198 |
|
|
2023
Q3 | $123 | Sell |
1,020
-2,206
| -68% | -$266 | ﹤0.01% | 216 |
|
|
2023
Q2 | $221 | Buy |
3,226
+1,598
| +98% | +$109 | ﹤0.01% | 232 |
|
|
2023
Q1 | $77 | Hold |
1,628
| – | – | ﹤0.01% | 284 |
|
|
2022
Q4 | $81 | Buy |
1,628
+1
| +0.1% | – | ﹤0.01% | 321 |
|
|
2022
Q3 | $0 | Hold |
1,627
| – | – | ﹤0.01% | 345 |
|
|
2022
Q2 | $0 | Buy |
1,627
+285
| +21% | – | ﹤0.01% | 348 |
|
|
2022
Q1 | $0 | Hold |
1,342
| – | – | ﹤0.01% | 268 |
|
|
2021
Q4 | $1K | Buy |
+1,342
| New | +$1K | ﹤0.01% | 216 |
|